Haloprogin
From Wikipedia, the free encyclopedia
"Polik" redirects here. For other uses, see Polik (disambiguation).
| Clinical data | |
|---|---|
| Routes of administration |
Topical |
| ATC code | D01AE11 (WHO) |
| Legal status | |
| Legal status |
|
| Identifiers | |
|
|
| CAS Number | 777-11-7 |
| PubChem (CID) | 3561 |
| DrugBank | DB00793 |
| ChemSpider | 3440 |
| UNII | AIU7053OWL |
| KEGG | D00339 |
| ChEMBL | CHEMBL1289 |
| ECHA InfoCard | 100.011.169 |
| Chemical and physical data | |
| Formula | C9H4Cl3IO |
| Molar mass | 361.39 g/mol |
| 3D model (Jmol) | Interactive image |
| Melting point | 113.5 °C (236.3 °F) |
| Solubility in water | Insoluble mg/mL (20 °C) |
|
|
|
|
| (verify) | |
Haloprogin is an antifungal drug used to treat athlete's foot and other fungal infections. It is marketed in creams under the trade names Halotex, Mycanden, Mycilan, and Polik.
Action[edit]
Haloprogin was previously used in 1% topical creams as an antifungal agent. It was marketed over-the-counter primarily to treat tinea infections of the skin. The mechanism of action is unknown.[1]
Haloprogin had a high incidence of side effects including: irritation, burning, vesiculation (blisters), scaling, and itching. It has since been discontinued due to the emergence of more modern antifungals with fewer side effects.[2]
References[edit]
- ^ "Haloprogin". Drugs@FDA. Food and Drug Administration. Retrieved 2007-02-17.
- ^ "Haloprogin". DrugBank. University of Alberta. Nov 6, 2006. Retrieved 2007-02-17.
| This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
| This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |